ganitumab
Showing 1 - 9 of 9
Ewing Sarcoma, Ewing's Sarcoma Recurrent Trial in Boston (Palbociclib, Ganitumab)
Active, not recruiting
- Ewing Sarcoma
- Ewing's Sarcoma Recurrent
- Palbociclib
- Ganitumab
-
Boston, Massachusetts
- +2 more
Mar 21, 2022
Rhabdomyosarcoma, Rhabdomyosarcoma, Alveolar, Rhabdomyosarcoma, Embryonal Trial in Los Angeles, Bethesda (Dasatinib, Ganitumab)
Terminated
- Rhabdomyosarcoma
- +2 more
- Dasatinib
- Ganitumab
-
Los Angeles, California
- +1 more
Mar 17, 2022
Advanced Solid Tumors, Carcinoid, Colorectal Cancer Trial in Poland, Spain, United States (Modified FOLFOX6, Conatumumab,
Completed
- Advanced Solid Tumors
- +8 more
- Modified FOLFOX6
- +3 more
-
Duarte, California
- +11 more
Feb 3, 2021
Metastatic Ewing Sarcoma, Metastatic Malignant Tumor in the Bone, Metastatic Malignant Tumor in the Bone Marrow Trial in Canada,
Active, not recruiting
- Metastatic Ewing Sarcoma
- +5 more
- Cyclophosphamide
- +11 more
-
Birmingham, Alabama
- +316 more
Jan 28, 2023
Ewing Sarcoma Trial (Ganitumab)
No longer available
- Ewing Sarcoma
- Ganitumab
- (no location specified)
Mar 26, 2019
Pancreatic Cancer Trial (biological, drug, other)
Withdrawn
- Pancreatic Cancer
- ganitumab
- +6 more
- (no location specified)
Jun 27, 2016
Metastatic Colorectal Cancer Trial (Panitumumab, Ganitumab, Irinotecan)
Completed
- Metastatic Colorectal Cancer
- Panitumumab
- +2 more
- (no location specified)
Jan 7, 2016
Pancreatic Cancer Trial in United States (biological, drug, radiation)
Completed
- Pancreatic Cancer
- ganitumab
- +3 more
-
Orange, California
- +9 more
Nov 14, 2015